NexImmune, Inc. (NEXI)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
NexImmune Market Cap
NexImmune has a market cap or net worth of $139.00 as of May 9, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
139.00
Enterprise Value
-2.42M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 12, 2021, NexImmune's market cap has decreased from 545.88M to 139.00, a decrease of -100.00%. That is a compound annual growth rate of -97.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 139.00 | -99.91% |
| Dec 31, 2024 | 160.46K | -93.17% |
| Dec 29, 2023 | 2.35M | -62.95% |
| Dec 30, 2022 | 6.34M | -93.94% |
| Dec 31, 2021 | 104.70M | -80.82% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 729.60M |
| Tian'an Technology Group | 568.98M |
| Glass House Brands | 484.30M |
| Elite Pharmaceuticals | 448.25M |
| CytoDyn | 401.33M |
| Northwest Biotherapeutics | 390.49M |